A Murine Myh6MerCreMer Knock-In Allele Specifically Mediates Temporal Genetic Deletion in Cardiomyocytes after Tamoxifen Induction.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4512710)

Published in PLoS One on July 23, 2015

Authors

Jianyun Yan1, Lu Zhang1, Nishat Sultana1, David S Park2, Akshay Shekhar2, Lei Bu2, Jun Hu1, Shegufta Razzaque1, Chen-Leng Cai1

Author Affiliations

1: Department of Developmental and Regenerative Biology, The Black Family Stem Cell Institute, and The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States of America.
2: Leon H. Charney Division of Cardiology, New York University School of Medicine, New York, NY, United States of America.

Articles cited by this

Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet (1999) 55.63

A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci (2009) 21.94

The incidence of congenital heart disease. J Am Coll Cardiol (2002) 16.13

Widespread recombinase expression using FLPeR (flipper) mice. Genesis (2001) 7.08

Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res (2001) 6.15

Developmental regulation of myosin gene expression in mouse cardiac muscle. J Cell Biol (1990) 3.54

Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res (1996) 3.37

Cardiomyocyte cell cycle control and growth estimation in vivo--an analysis based on cardiomyocyte nuclei. Cardiovasc Res (2010) 3.00

Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell (2004) 2.64

Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest (1996) 2.63

Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res (1991) 2.34

Regulation of smooth muscle alpha-actin expression in vivo is dependent on CArG elements within the 5' and first intron promoter regions. Circ Res (1999) 2.20

Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models. Circ Res (2009) 2.11

Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure. Genes Dev (2013) 1.99

Development of heart valves requires Gata4 expression in endothelial-derived cells. Development (2006) 1.90

MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure. Circulation (2006) 1.80

Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase. J Card Fail (2006) 1.79

Mutation in myosin heavy chain 6 causes atrial septal defect. Nat Genet (2005) 1.76

With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure. J Mol Cell Cardiol (2008) 1.74

Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy. Circulation (2005) 1.67

Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation (2011) 1.57

System for tamoxifen-inducible expression of cre-recombinase from the Foxa2 locus in mice. Dev Dyn (2008) 1.37

Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. Dev Biol (1996) 1.34

Notch signaling contributes to the expression of cardiac markers in human circulating progenitor cells. Circ Res (2007) 1.25

New approaches in small animal echocardiography: imaging the sounds of silence. Am J Physiol Heart Circ Physiol (2011) 1.20

Moderate and high amounts of tamoxifen in αMHC-MerCreMer mice induce a DNA damage response, leading to heart failure and death. Dis Model Mech (2013) 1.16

Tbx5-hedgehog molecular networks are essential in the second heart field for atrial septation. Dev Cell (2012) 1.16

Cardiac fibrosis in mice expressing an inducible myocardial-specific Cre driver. Dis Model Mech (2013) 1.15

Existing cardiomyocytes generate cardiomyocytes at a low rate after birth in mice. Proc Natl Acad Sci U S A (2014) 1.12

The Notch pathway controls fibrotic and regenerative repair in the adult heart. Eur Heart J (2012) 1.12

Systolic dysfunction in cardiac-specific ligand-inducible MerCreMer transgenic mice. Am J Physiol Heart Circ Physiol (2011) 1.06

Inducible cardiomyocyte-specific gene disruption directed by the rat Tnnt2 promoter in the mouse. Genesis (2010) 1.02

Complex genetics and the etiology of human congenital heart disease. Cold Spring Harb Perspect Med (2014) 1.01

Inducible gene expression and gene modification in transgenic mice. J Am Soc Nephrol (2000) 1.00

Cre-loxP DNA recombination is possible with only minimal unspecific transcriptional changes and without cardiomyopathy in Tg(alphaMHC-MerCreMer) mice. Am J Physiol Heart Circ Physiol (2010) 1.00

Hand2 function in second heart field progenitors is essential for cardiogenesis. Dev Biol (2010) 0.99

The molecular genetics of congenital heart disease: a review of recent developments. Curr Opin Cardiol (2010) 0.96

Tbx20 acts upstream of Wnt signaling to regulate endocardial cushion formation and valve remodeling during mouse cardiogenesis. Development (2013) 0.95

Cardiac alpha-myosin (MYH6) is the predominant sarcomeric disease gene for familial atrial septal defects. PLoS One (2011) 0.93

Congenital heart disease: entering a new era of human genetics. Circ Res (2014) 0.84

Genetic modification of the heart: exploring necessity and sufficiency in the past 10 years. J Mol Cell Cardiol (2004) 0.82

Smad4 regulates ureteral smooth muscle cell differentiation during mouse embryogenesis. PLoS One (2014) 0.80

Generation of a tamoxifen inducible Tnnt2MerCreMer knock-in mouse model for cardiac studies. Genesis (2015) 0.78